Compare Hims and Hers Health Inc (HIMS) vs Liberty Global Ltd Class C (LBTYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Liberty Global Ltd Class C — how do they compare? Hims and Hers Health Inc trades at $29.04 (market cap $6.55B), while Liberty Global Ltd Class C trades at $8.56 (market cap $3.06B). The key difference: Hims and Hers Health Inc is far larger — about 2.1× Liberty Global Ltd Class C's market cap, and Hims and Hers Health Inc is trading nearer its 52-week high, Liberty Global Ltd Class C nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Liberty Global Ltd Class C for 21 Days on average.
| HIMS | LBTYK | |
|---|---|---|
Market Cap | $6.55B | $3.06B |
Volume | 14,842,814 | 2,508,956 |
Sector | Health | Media |
52-Week High | $62.76 | $12.67 |
52-Week Low | $14.52 | $8.75 |
Typical Hold Time | 21 Days | 21 Days |
Enterprise Value | $7.25B | $9.72B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health (HIMS) trades at $29.38, down 0.54% on the day, amid a bearish technical signal and mixed earnings history. The company reported revenue of $2.35 billion in 2025 with a net income of $128.37 million, but 2026 projections show a net loss of $142 million. Valuation ratios are elevated with a P/E of 57.14 and EV/EBITDA of 205.86. Recent news highlights multiple securities class action lawsuits filed against the company, creating investor uncertainty.
The outlook is cautious due to profitability concerns and legal risks. Analyst consensus is a Hold with a $32.17 price target, suggesting limited upside. Key risks include ongoing litigation, negative profit margins, and high valuation multiples. Investment appeal hinges on the company's ability to return to profitability and navigate regulatory challenges.
LBTYK trades at $8.65, down 3.03% today and near 52-week lows. The stock shows bearish technical signals with negative earnings trends, including a Q3 2026 net loss of -$3.0B. However, strong analyst support (69% buy ratings) and a $12.67 price target suggest potential upside. Recent developments include the Ziggo Group spin-off preparation and AI partnership with Sierra.
The outlook remains cautious due to persistent losses and bearish technicals, but strategic moves like Ziggo's 2027 listing and solid cash flow ($602M net in 2026) offer recovery potential. Key risks include execution challenges and competitive pressures, while institutional sentiment provides a floor for valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Liberty Global Ltd Class C
Liberty Global is a world leader in converged broadband, video, and mobile communications. It operates large-scale fiber and 5G networks across Europe, providing essential digital services to millions of customers.
Read more on LBTYK →
